Story perspectives

Study Finds Anti-Amyloid Drugs Ineffective for Alzheimer's Treatment

4/16/2026

Summary

Story summary

The Cochrane analysis of 17 trials with over 20,000 participants found anti-amyloid drugs do not significantly improve Alzheimer’s outcomes.
The analysis found the drugs' effects on cognitive decline and dementia severity to be trivial.
Critics say the review mixed positive and negative trials, potentially misrepresenting newer treatments like lecanemab and donanemab.
Some researchers defend the methodology, while others urge nuanced interpretation and note side effects such as brain swelling.

1 of 1

Story summary

The Cochrane analysis of 17 trials with over 20,000 participants found anti-amyloid drugs do not significantly improve Alzheimer’s outcomes.
The analysis found the drugs' effects on cognitive decline and dementia severity to be trivial.
Critics say the review mixed positive and negative trials, potentially misrepresenting newer treatments like lecanemab and donanemab.
Some researchers defend the methodology, while others urge nuanced interpretation and note side effects such as brain swelling.